News

Fifteen years ago Douglas Andres and his team produced data that showed mutations in an on-off switch called RIT1 are a novel driver for human lung cancer.

Jenna Hatcher is taking preventive health care into the emergency department, “because for many Kentuckians that’s where they find their medical home."

John D'Orazio studies hormonal pathways that protect the skin from sun damage and repair DNA.

A new metabolomics study suggests targeting a key enzyme may lead to novel drug development for lung cancer.

The grant funds UK Rural Cancer Prevention Center's work on screening and prevention of colorectal cancer.

On July 10, 2014, UK announced a project in Eastern Kentucky to promote a new at-home cancer screening test.

Dr. Susanne Arnold is studying potential environmental reasons for high lung cancer rates in Eastern KY.

In July 2013, Markey Cancer Center joined an elite group of centers with NCI Designation.

Phoebe Glazer is making light-activated, ruthenium-based molecules that will kill only cancerous cells.

Peter Zhou found that triple-negative breast cancer cells are missing a key enzyme.